USPTO trademark

Sanofi design mark 4641478

CancelledUSPTOFigurative markClass 1Class 5Class 9Class 10+6

"Design mark 4641478" is a figurative mark owned by Sanofi, filed at the USPTO on March 25, 2011. It was cancelled and covers classes 1, 5, 9, 10, 16, 35, 38, 40, 41 and 44.

Official USPTO record
Sanofi design mark 4641478 trademark as filed
As filed with the USPTO
Status
Cancelled
Since May 30, 2025
Filed
March 25, 2011
Registered
November 18, 2014
Expires
Not recorded
Application no.
85277159
Registration no.
4641478
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
10 classes
Ownership

Who owns Sanofi design mark 4641478

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Sanofi

Paris, France

3,998 trademarks in the portfolioView company

Representative

Karen Lim

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services Sanofi design mark 4641478 is filed for, grouped by Nice class.

  • [ chemicals for use in the manufacture of pharmaceutical preparations and substances ]

  • house mark for a full line of vaccines, pharmaceutical preparations both prescription and over-the-counter, for [ both ] human [ and animal ] use

  • [ computer software for pharmaceutical and medical development, computer software for database management in the field of healthcare; computers and computer software for use in searching for, managing, and providing healthcare information in patient records management, in word processing, in database management, and as a spreadsheet in the field of healthcare by physicians and healthcare technicians, pharmacists, scientists, researchers and other personnel; ] audio and video recordings featuring healthcare information and pharmaceutical and medical developments

  • [ surgical, medical and veterinary apparatus and instruments, namely, inhalers for therapeutic use sold empty and parts and fittings therefor; devices for the injection of medicines, namely, pens for injection ]

  • [ newspapers, periodicals, journals, and books in the fields of pharmaceuticals and medical developments ]

  • [ Business consultation services; consultation services, namely, providing consumer information regarding products; advertising and marketing; business administration and management in the fields of healthcare; distribution of printed promotional materials in the field of healthcare; ] promoting public awareness regarding healthcare

  • [ telecommunications services, namely, transmission of information via telephone and computer terminals through internet web sites regarding healthcare; ] transmission of information for others in the field of healthcare, communication of information addressed to patients or healthcare professionals via computer and internet [ ; providing online chat rooms and electronic bulletin boards for the transmission of messages among computer users concerning healthcare, pharmaceuticals, pharmaceutical and medical developments ]

  • custom manufacture of chemical, biochemical, and cell based assays on behalf of others; custom manufacture of pharmaceuticals; storage and delivery of pharmaceutical products, chemical products for pharmaceutical use

  • educational services, namely, conducting seminars, working groups, training and conferences in the field of healthcare; publishing of periodicals, books, guides and databases in the medical field, and providing digital educational materials therewith; conducting online educational exhibitions featuring displays and interactive exhibits in the field of healthcare

  • Providing medical information and educational information in the field of healthcare; health care services; medical consultation; disease management programs concerning healthcare

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Cancelled sec. 8 (10-yr)/expired section 9
  2. Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  3. Applicant/correspondence changes (non-responsive) entered
  4. Teas change of correspondence received
  5. Attorney/dom.rep.revoked and/or appointed
  6. Teas revoke/app/change addr of atty/dom rep received
  7. Teas change of owner address received
  8. Notice of acceptance of sec. 8 - e-mailed
  9. Registered - partial sec. 8 (6-yr) accepted
  10. Case assigned to post registration paralegal

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About Sanofi design mark 4641478

Who owns the trademark "Design mark 4641478"?

The USPTO trademark "Design mark 4641478" (application 85277159) is owned by Sanofi.

What is the status of "Design mark 4641478"?

Its status at the USPTO is: cancelled.

When was "Design mark 4641478" registered?

It was registered on November 18, 2014.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Sanofi design mark 4641478 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2c14-5d97-73b8-b21f-df752141fd4e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c14-5d97-73b8-b21f-df752141fd4e",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "inactive",
    "stage": "cancelled"
  },
  "office_code": "US",
  "application_number": "85277159",
  "filing_date": "2011-03-25",
  "nice_classes": [
    1,
    5,
    9,
    10,
    16,
    35,
    38,
    40,
    41,
    44
  ],
  "owners": [
    {
      "name": "SANOFI",
      "entity_id": "ent_019eb6f6-62f9-773d-a835-46d137e82556"
    }
  ]
}